CANbridge Pharmaceuticals Inc. Financial Overview
CANbridge Pharmaceuticals Inc.'s market cap is currently HK$1.12B. The company's EPS TTM is HK$0.15376082540000002; its P/E ratio is -6.28; CANbridge Pharmaceuticals Inc. is scheduled to report earnings on August 31, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
